Oramed Pharmaceuticals (ORMP) Revenue (2016 - 2025)
Oramed Pharmaceuticals (ORMP) posted Revenue of $2.0 million for Q1 2025, up 196.74% on a QoQ basis from $674000.0 in Q2 2023.
Oramed Pharmaceuticals (ORMP) Revenue (2016 - 2025) Analysis & Trends
Oramed Pharmaceuticals' Revenue history runs 8 years deep, the most recent figure standing at $2.0 million for Q1 2025.
- Quarterly Revenue changed N/A year-over-year to $2.0 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $2.0 million (changed N/A YoY) and the FY2025 annual result came in at $2.0 million, changed N/A from the prior year.
- Revenue was $2.0 million for Q1 2025 at Oramed Pharmaceuticals, up from $674000.0 in the prior quarter.
- Across five years, Revenue topped out at $2.7 million in Q3 2021 and bottomed at $666000.0 in Q1 2022.
- A 4-year average of $1.1 million and a median of $678000.0 in 2022 frame the typical range for Revenue.
- Peak annual rise in Revenue reached 0.0% in 2023, while the deepest fall reached 0.0% in 2023.
- Oramed Pharmaceuticals' Revenue stood at $2.7 million in 2021, then sank by 66.56% to $904000.0 in 2022, then decreased by 25.44% to $674000.0 in 2023, then jumped by 196.74% to $2.0 million in 2025.
- Business Quant data shows ORMP's Revenue at $2.0 million in Q1 2025, $674000.0 in Q2 2023, and $666000.0 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 2.00 Mn |
| Jun 30, 2023 | 674,000.00 |
| Mar 31, 2023 | 666,000.00 |
| Dec 31, 2022 | 904,000.00 |
| Sep 30, 2022 | 682,000.00 |
| Jun 30, 2022 | 674,000.00 |
| Mar 31, 2022 | 666,000.00 |
| Aug 31, 2021 | 2.70 Mn |
| Nov 30, 2019 | 674,000.00 |
| Aug 31, 2019 | 681,000.00 |
| May 31, 2019 | 682,000.00 |
| Feb 28, 2019 | 666,000.00 |
| Nov 30, 2018 | 674,000.00 |
| Aug 31, 2018 | 617,000.00 |
| May 31, 2018 | 617,000.00 |
| Feb 28, 2018 | 604,000.00 |
| Nov 30, 2017 | 611,000.00 |
| Aug 31, 2017 | 618,000.00 |
| May 31, 2017 | 617,000.00 |
| Feb 28, 2017 | 611,000.00 |